Centessa Pharmaceuticals plc - 存託憑證(普通股)
US ˙ NasdaqGS ˙ US1523091007

SecurityCNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership27,214 shares
Latest Disclosed Value $ 367,661
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 13.79% increase in ownership of CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 27,214 shares of Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) (US:CNTA) valued at $367,661 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 23,916 shares of Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock). This represents a change in shares of 13.79% during the quarter. The current value of the position is $1,078,219 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP CENTESSA PHARMACEUTICALS LTD ADR EC US1523091007 27,214 3,298 13.79 368 -1.08 0.0049
2025-04-25 2025-02-28 NP CENTESSA PHARMACEUTICALS LTD ADR EC US1523091007 23,916 594 2.55 372 -11.03 0.0050
2025-01-27 2024-11-30 NP CENTESSA PHARMACEUTICALS LTD ADR EC US1523091007 23,322 23,322 418 0.0057
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.